Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
MLTX - MoonLake Immunotherapeutics - Stock Price Chart
TickerMLTX [NASD]
CompanyMoonLake Immunotherapeutics
CountrySwitzerland
IndustryBiotechnology
Market Cap3.21BEPS (ttm)-0.90
P/E-EPS this Y-107.65%
Forward P/E-EPS next Y-54.55%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B6.16EPS Q/Q-66.45%
Dividend-Sales Q/Q-
Insider Own16.53%Inst Own96.72%
Insider Trans0.00%Inst Trans0.54%
Short Float15.13%EarningsAug 07/b
Analyst Recom1.40Target Price74.00
Avg Volume318.85K52W Range35.11 - 64.98
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Santos da Silva JorgeChief Executive OfficerFeb 27 '24Sale55.0062,8103,454,5503,043,619Feb 29 07:56 PM
Santos da Silva JorgeChief Executive OfficerFeb 28 '24Sale55.0056,0653,083,5752,987,554Feb 29 07:56 PM
Santos da Silva JorgeChief Executive OfficerFeb 29 '24Sale55.894,740264,9192,982,814Feb 29 07:56 PM
Reich KristianChief Scientific OfficerFeb 28 '24Sale55.0031,9101,755,0502,925,573Feb 29 07:53 PM
Reich KristianChief Scientific OfficerFeb 27 '24Sale55.0029,4911,622,0052,957,483Feb 29 07:53 PM
CNTA - Centessa Pharmaceuticals plc ADR - Stock Price Chart
TickerCNTA [NASD]
CompanyCentessa Pharmaceuticals plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap1.71BEPS (ttm)-1.56
P/E-EPS this Y0.09%
Forward P/E-EPS next Y-6.74%
PEG-EPS past 5Y-
P/S247.33EPS next 5Y-
P/B5.96EPS Q/Q-52.67%
Dividend-Sales Q/Q-
Insider Own33.28%Inst Own43.30%
Insider Trans-0.96%Inst Trans0.05%
Short Float2.61%EarningsAug 13/b
Analyst Recom1.29Target Price20.00
Avg Volume432.09K52W Range5.15 - 17.25
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weinhoff Gregory MChief Business OfficerSep 10 '24Option Exercise5.8430,000175,200253,369Sep 12 08:01 PM
Weinhoff Gregory MChief Business OfficerSep 10 '24Sale17.0030,000510,000223,369Sep 12 08:01 PM
SAHA SAURABHChief Executive OfficerSep 10 '24Option Exercise5.84175,0001,022,000951,924Sep 12 08:01 PM
SAHA SAURABHChief Executive OfficerSep 10 '24Sale16.52175,0002,891,822776,924Sep 12 08:01 PM
SAHA SAURABHOfficerSep 10 '24Proposed Sale16.52175,0002,891,822Sep 10 04:06 PM
U - Unity Software Inc - Stock Price Chart
TickerU [NYSE]
CompanyUnity Software Inc
CountryUSA
IndustrySoftware - Application
Market Cap7.50BEPS (ttm)-2.05
P/E-EPS this Y-20.36%
Forward P/E24.92EPS next Y-12.19%
PEG-EPS past 5Y-34.36%
P/S3.64EPS next 5Y-
P/B2.35EPS Q/Q36.68%
Dividend-Sales Q/Q-15.79%
Insider Own28.71%Inst Own53.46%
Insider Trans-0.29%Inst Trans-0.34%
Short Float9.63%EarningsAug 08/a
Analyst Recom2.41Target Price19.61
Avg Volume10.22M52W Range13.90 - 43.54
Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
The FelixOfficerSep 12 '24Proposed Sale17.8930,000536,761Sep 12 04:44 PM
Carpenter Carol W.Former AffiliateSep 03 '24Proposed Sale17.953,00053,850Sep 03 04:06 PM
Visoso Luis FelipeFormer AffiliateAug 30 '24Proposed Sale16.19161,3222,611,232Aug 30 04:34 PM
The FelixSVP Product & Technology, GrowAug 26 '24Sale17.616,272110,450453,679Aug 27 03:18 PM
Gupta AnirmaSVP, Chief Legal OfficerAug 26 '24Sale17.6310,998193,895586,276Aug 27 03:15 PM
IE - Ivanhoe Electric Inc - Stock Price Chart
TickerIE [AMEX, RUT]
CompanyIvanhoe Electric Inc
CountryUSA
IndustryCopper
Market Cap916.24MEPS (ttm)-1.99
P/E-EPS this Y35.38%
Forward P/E-EPS next Y49.75%
PEG-EPS past 5Y-64.45%
P/S326.07EPS next 5Y-
P/B3.17EPS Q/Q5.38%
Dividend-Sales Q/Q-59.06%
Insider Own39.41%Inst Own56.98%
Insider Trans-0.14%Inst Trans7.13%
Short Float10.10%EarningsAug 09
Analyst Recom1.20Target Price16.80
Avg Volume845.95K52W Range6.31 - 15.97
Ivanhoe Electric, Inc. is a minerals exploration and development company which focuses on developing mines from mineral deposits. Its projects include Santa Cruz Copper and Tintic Copper-Gold Projects. It operates through the following segments: Critical Metals, Data Processing, and Energy Storage. The Critical Metals segment handles mineral project exploration and development with a focus on identifying and developing mineral projects, and ultimately mines, associated with the metals necessary for electrification. The Data Processing segment provides data analytics, geophysical modeling, and artificial intelligence services for mineral, oil and gas, and water exploration industries. The Energy Storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage. The company was founded on July 14, 2020 and is headquartered in Tempe, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gibson Mark Andrew StuartChief Geophysics OfficerMay 28 '24Option Exercise2.4920,00049,800280,272May 30 04:05 PM
Gibson Mark Andrew StuartChief Geophysics OfficerMay 20 '24Sale12.1625,000304,000260,272May 21 06:33 PM
Gibson Mark Andrew StuartChief Operating OfficerMay 16 '24Sale12.4528,344352,883301,928May 17 03:31 PM
Gibson Mark Andrew StuartChief Operating OfficerMay 17 '24Sale12.2211,656142,436290,272May 17 03:31 PM
Kuntz Glen NickolasSVP, Mine DevelopmentMar 06 '24Buy8.231,34211,0453,042Mar 07 03:23 PM
MCVT - Mill City Ventures III Ltd - Stock Price Chart
TickerMCVT [NASD]
CompanyMill City Ventures III Ltd
CountryUSA
IndustryCredit Services
Market Cap18.59MEPS (ttm)0.04
P/E70.29EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S5.14EPS next 5Y-
P/B0.96EPS Q/Q457.02%
Dividend-Sales Q/Q30.19%
Insider Own71.85%Inst Own0.53%
Insider Trans0.00%Inst Trans-
Short Float0.61%Earnings-
Analyst Recom1.00Target Price5.84
Avg Volume4.58K52W Range2.10 - 3.77
Mill City Ventures III Ltd. engages in the business of providing short-term specialty finance solutions. The company was founded by Douglas Michael Polinsky and Joseph Anthony Geraci II on January 10, 2006 and is headquartered in Wayzata, MN.
BIVI - BioVie Inc - Stock Price Chart
TickerBIVI [NASD]
CompanyBioVie Inc
CountryUSA
IndustryBiotechnology
Market Cap19.40MEPS (ttm)-9.62
P/E-EPS this Y50.85%
Forward P/E-EPS next Y-
PEG-EPS past 5Y16.23%
P/S-EPS next 5Y-
P/B1.02EPS Q/Q53.06%
Dividend-Sales Q/Q-
Insider Own39.73%Inst Own7.31%
Insider Trans0.00%Inst Trans-82.84%
Short Float4.13%EarningsMay 10
Analyst Recom1.00Target Price30.00
Avg Volume101.27K52W Range2.07 - 58.20
Sep-03-24 08:00AM BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID (GlobeNewswire)
Aug-27-24 08:45AM BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting (GlobeNewswire)
Aug-13-24 08:00AM BioVie to Present Overview of Bezisterim Clinical Data on Longevity at 11th Aging Research and Drug Discovery Meeting (GlobeNewswire)
Aug-12-24 07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -10.08%
Aug-08-24 06:00AM BioVie Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson's Disease (GlobeNewswire) +13.30%
Aug-06-24 04:40PM BioVie Inc. Announces Reverse Stock Split (GlobeNewswire) -21.40% -5.63%
Jul-05-24 09:00AM BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Jun-25-24 08:00AM BioVie Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with Early Parkinson's Disease at ATMRD 2024 (GlobeNewswire) -5.32%
Jun-21-24 09:00AM BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Jun-20-24 08:00AM BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson's Disease at 2024 ATMRD Congress (GlobeNewswire)
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GORLIN STEVEDirectorDec 01 '23Sale1.6975,680127,89946,358Dec 06 04:16 PM
DO CUONG VPresident & CEONov 30 '23Buy1.7810,00017,80068,759Dec 01 06:26 PM
AUNA - Auna S.A. - Stock Price Chart
TickerAUNA [NYSE]
CompanyAuna S.A.
CountryLuxembourg
IndustryMedical Care Facilities
Market Cap231.00MEPS (ttm)-1.58
P/E-EPS this Y155.49%
Forward P/E9.24EPS next Y63.49%
PEG-EPS past 5Y-
P/S0.20EPS next 5Y-
P/B0.60EPS Q/Q25.93%
Dividend-Sales Q/Q17.06%
Insider Own20.46%Inst Own43.23%
Insider Trans0.00%Inst Trans-
Short Float1.05%EarningsAug 21/a
Analyst Recom1.00Target Price15.33
Avg Volume124.16K52W Range6.17 - 10.85
Auna SA engages in the provision of healthcare and medical services. It operates through the following segments: Oncosalud Peru, Healthcare Services in Peru, and Healthcare Services in Colombia. The Oncosalud Peru segment offers prepaid oncology plans and oncology services provided at Oncosalud facilities. The Healthcare Services in Peru segment provides medical services in Peru. The Healthcare Services in Colombia segment manages and operates medical centers in Colombia. The company was founded on November 4, 2008 and is headquartered in Luxembourg.
CSBR - Champions Oncology Inc - Stock Price Chart
TickerCSBR [NASD]
CompanyChampions Oncology Inc
CountryUSA
IndustryBiotechnology
Market Cap60.61MEPS (ttm)-0.26
P/E-EPS this Y128.26%
Forward P/E23.47EPS next Y46.15%
PEG-EPS past 5Y-
P/S1.17EPS next 5Y15.00%
P/B-EPS Q/Q147.37%
Dividend-Sales Q/Q11.94%
Insider Own55.98%Inst Own20.10%
Insider Trans0.00%Inst Trans-0.68%
Short Float0.84%EarningsSep 11/a
Analyst Recom1.00Target Price6.00
Avg Volume7.06K52W Range3.60 - 7.13
Sep-12-24Upgrade Craig Hallum Hold → Buy $6
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mendelson Daniel NewmanDirectorJan 12 '24Buy6.501,0006,500198,625Jan 16 11:45 AM
Mendelson Daniel NewmanDirectorJan 11 '24Buy6.272,00012,540197,625Jan 12 12:47 PM
Mendelson Daniel NewmanDirectorJan 10 '24Buy6.312,94418,577195,625Jan 11 10:57 AM
Mendelson Daniel NewmanDirectorJan 09 '24Buy6.253,00018,750192,681Jan 10 08:57 AM
Mendelson Daniel NewmanDirectorJan 08 '24Buy6.151,0006,150189,681Jan 09 09:08 AM
CSLR - Complete Solaria Inc. - Stock Price Chart
TickerCSLR [NASD]
CompanyComplete Solaria Inc.
CountryUSA
IndustrySolar
Market Cap132.31MEPS (ttm)-2.48
P/E-EPS this Y89.73%
Forward P/E-EPS next Y98.46%
PEG-EPS past 5Y-
P/S2.21EPS next 5Y-
P/B-EPS Q/Q-70.06%
Dividend-Sales Q/Q-
Insider Own39.94%Inst Own20.85%
Insider Trans-0.45%Inst Trans2.44%
Short Float2.01%EarningsAug 14/b
Analyst Recom1.00Target Price4.50
Avg Volume2.47M52W Range0.20 - 2.92
Complete Solaria, Inc. engages in the provision of solar services. It offers sales enablement, project management, partner coordination, and customer communication. The company is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gishen AdamDirectorAug 19 '24Sale1.7515,52627,177337,742Aug 21 04:30 PM
Thiam TidjaneDirectorAug 16 '24Sale1.5930,00047,700158,624Aug 20 05:54 PM
Carlyle Group Inc.10% OwnerJul 18 '24Sale1.4035,14349,2004,901,340Aug 07 04:48 PM
CRSEF Solis Holdings, L.L.C.10% OwnerJul 18 '24Sale1.4035,14349,2004,901,340Aug 07 04:30 PM
NGD - New Gold Inc - Stock Price Chart
TickerNGD [AMEX]
CompanyNew Gold Inc
CountryCanada
IndustryGold
Market Cap2.28BEPS (ttm)-0.04
P/E-EPS this Y114.24%
Forward P/E9.99EPS next Y92.85%
PEG-EPS past 5Y46.46%
P/S2.84EPS next 5Y-
P/B2.40EPS Q/Q1976.32%
Dividend-Sales Q/Q15.12%
Insider Own4.94%Inst Own50.97%
Insider Trans0.00%Inst Trans0.72%
Short Float0.69%EarningsJul 30/a
Analyst Recom2.10Target Price2.79
Avg Volume7.73M52W Range0.86 - 2.73
New Gold, Inc. is a gold mining company, which engages in the operation, development, and exploration of mineral properties. Its portfolio includes Rainy RIver, New Afton, and Cerro San Pedro. The company was founded on January 31, 1980 and is headquartered in Toronto, Canada.
15678910111213141520